What's Going On With Health Technology Company Masimo Shares Today?
What's Going On With Health Technology Company Masimo Shares Today?
Masimo Corporation (NASDAQ:MASI) shares are trading lower on Tuesday.
麥斯莫醫療公司（納斯達克股票代碼：MASI）的股價在週二下跌。
Yesterday, Masimo reportedly disclosed that a potential joint venture partner is poised to bid between $850 million and $950 million for its consumer business encompassing health and audio products, reported Reuters.
據路透社報道，麥斯莫昨天透露，一家潛在的合資夥伴有望出價介於8500萬美元和9500萬美元之間，收購其消費業務，其業務囊括健康和音頻產品。
Masimo is currently engaged in active discussions with this unnamed partner regarding the joint venture terms, including Masimo's proposal to manage ongoing litigation outcomes with Apple Inc. (NASDAQ:AAPL).
目前，麥斯莫正在與這家未知合作伙伴進行積極的討論，包括麥斯莫管理與蘋果公司（納斯達克股票代碼：AAPL）的持續訴訟結果的提議。
Also Read: Masimo CEO 'Wholeheartedly' Feels Apple Watch Users Are Better Off Without Blood Oxygen Monitoring Feature
還有：麥斯莫的CEO表示，認爲Apple Watch用戶沒有血氧監測功能會更好。
Today, the company disclosed the preliminary results for the second quarter of 2024.
今天，該公司披露了2024年第二季度的初步業績。
The company's consolidated revenue is expected to be approximately $496 million (street view stands at $493.56 million), representing 9% growth on a reported basis and 10% growth on a constant currency basis.
該公司預計的綜合營業收入約爲49600萬美元（大衆觀點爲49356萬美元），按報告基礎增長9％，按恒定貨幣基礎增長10％。
Joe Kiani, Chairman and CEO of Masimo, stated, "We are excited to see the growth and strength of our healthcare business in the second quarter combined with a very strong order backlog as we enter the third quarter."
麥斯莫公司的董事長兼首席執行官Joe Kiani表示：“我們很高興看到我們的醫療業務在第二季度取得了增長和強勁的訂單積壓，進入第三季度。”
Masimo's healthcare revenue is expected to be approximately $344 million, representing 22% growth on a reported basis and 23% growth on a constant currency basis.
麥斯莫的醫療保健業務營業收入預計約爲34400萬美元，按報告基礎增長22％，按恒定貨幣基礎增長23％。
Sensor utilization and hospital census have meaningfully improved from last year.
傳感器的使用和醫院普查情況與去年相比有了明顯的改善。
The company's non-healthcare revenue is expected to be approximately $152 million, representing a 13% decline on a reported basis and an 11% decline on a constant currency basis.
該公司的非醫療業務營業收入預計約爲15200萬美元，按報告基礎下降13％，按恒定貨幣基礎下降11％。
"We achieved a record second quarter in terms of converting customers to our technologies with an expected $134 million of incremental contract value, which is the best sign of a healthy future for Masimo," Kiani added.
Kiani補充道：“我們創造了記錄，第二季度轉化顧客的技術合同預計增加了1.34億美元增量合同價值，這是麥斯莫未來健康的最好跡象。”
Price Action: MASI shares are trading lower by 2.64% to $109.68 at last check Tuesday.
MASI股票交易價格下跌2.64％，至109.68美元。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免責聲明：本內容部分使用人工智能工具生成，並經Benzinga編輯審核發佈。
- XPeng CEO Says Tesla's FSD Works Well In Silicon Valley: '2025 Will Be The ChatGPT Moment Of Fully Self-Driving!'
- 小鵬汽車CEO稱特斯拉的全自動駕駛系統在硅谷表現良好：“2025年將是chatgpt概念股的全自動駕駛時代！”
譯文內容由第三人軟體翻譯。